FDA Has Second Thoughts on Convalescent Plasma for COVID-19
The FDA has reversed course and authorized convalescent plasma as an emergency use authorization for COVID-19. The scientific community does not think this was a wise course of action.
Read Original Article: FDA Has Second Thoughts on Convalescent Plasma for COVID-19 »
